Cocrystal Pharma Inc (COCP):企業の財務・戦略的SWOT分析

◆英語タイトル:Cocrystal Pharma Inc (COCP) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH185703FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥76,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥115,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cocrystal Pharma Inc (Cocrystal Pharma), formerly Biozone Pharmaceuticals Inc, a subsidiary of MusclePharm Corp, is a clinical stage biotechnology company that discovers and develops novel antiviral therapeutics. The company provides treatments for chronic viral diseases. Its pipeline products include Nucleoside NS5B, NS5A, NNI NS5B, and NS3 Helicase. Cocrystal Pharma offers products such as non nucleoside inhibitors, novel pan-genotypic nucleoside prodrugs, and helicase inhibitors. The company’s novel pan-genotypic nucleoside pro-drugs are used in non-toxic, resisting drug-drug interactions, barrier to drug resistance, short duration treatment and others. Its novel antiviral therapeutics is used in treatments for serious and chronic viral diseases. The company operates in Tucker and Bothell. Cocrystal Pharma is headquartered in Tucker, Georgia, the US.

Cocrystal Pharma Inc Key Recent Developments

Mar 17,2021: Cocrystal Pharma reports 2020 financial results, provides business update including antiviral program milestones
Jan 19,2021: Cocrystal Pharma announces further development of Influenza A/B antiviral compounds by Merck under exclusive worldwide license and collaboration agreement
Jan 14,2021: Cocrystal to present at the 3rd annual reimagine Health Research symposium
Nov 16,2020: Cocrystal Pharma reports third quarter 2020 financial results and provides update on antiviral programs
Nov 10,2020: Cocrystal Pharma selected to present at the World Antiviral Conference

This comprehensive SWOT profile of Cocrystal Pharma Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Cocrystal Pharma Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Cocrystal Pharma Inc – Key Information
Cocrystal Pharma Inc – Overview
Cocrystal Pharma Inc – Key Employees
Cocrystal Pharma Inc – Key Employee Biographies
Cocrystal Pharma Inc – Key Operational Heads
Cocrystal Pharma Inc – Major Products and Services
Cocrystal Pharma Inc – History
Cocrystal Pharma Inc – Company Statement
Cocrystal Pharma Inc – Locations And Subsidiaries
Cocrystal Pharma Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Cocrystal Pharma Inc – Business Description
Cocrystal Pharma Inc – Corporate Strategy
Cocrystal Pharma Inc – SWOT Analysis
SWOT Analysis – Overview
Cocrystal Pharma Inc – Strengths
Cocrystal Pharma Inc – Weaknesses
Cocrystal Pharma Inc – Opportunities
Cocrystal Pharma Inc – Threats
Cocrystal Pharma Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Cocrystal Pharma Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Cocrystal Pharma Inc, Key Information
Cocrystal Pharma Inc, Key Ratios
Cocrystal Pharma Inc, Share Data
Cocrystal Pharma Inc, Major Products and Services
Cocrystal Pharma Inc, History
Cocrystal Pharma Inc, Key Employees
Cocrystal Pharma Inc, Key Employee Biographies
Cocrystal Pharma Inc, Key Operational Heads
Cocrystal Pharma Inc, Other Locations
Cocrystal Pharma Inc, Subsidiaries
Cocrystal Pharma Inc, Key Competitors
Cocrystal Pharma Inc, SWOT Analysis
Cocrystal Pharma Inc, Ratios based on current share price
Cocrystal Pharma Inc, Annual Ratios
Cocrystal Pharma Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Cocrystal Pharma Inc (COCP):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Consort Medical plc (CSRT):医療機器:M&Aディール及び事業提携情報
    Summary Consort Medical plc (Consort Medical) is a contract development and manufacturing organization (CDMO) with focus on medical device technologies for drug delivery. It develops, manufactures and markets high volume disposable medical devices for drug delivery and point-of-care (POC) diagnostic …
  • AirStrip Technologies Inc-医療機器分野:企業M&A・提携分析
    Summary AirStrip Technologies Inc (AirStrip) is a healthcare solution provider that offers medical software solutions and services. The company offers mobile interoperability platform, accelerator services and wireless maternal-fetal monitoring solutions. It caters its products to healthcare provide …
  • MCB Bank Ltd:企業の戦略・SWOT・財務情報
    MCB Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary MCB Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Organogenesis Inc:医療機器:M&Aディール及び事業提携情報
    Summary Organogenesis Inc (Organogenesis) is a regenerative medicine company that operates in the areas of bioactive wound healing and soft tissue regeneration. The company’s products include apligraf and dermagraft. Its dermagraft is used for the treatment of full-thickness diabetic foot ulcers. Or …
  • Rex Energy Corp (REXX):石油・ガス:M&Aディール及び事業提携情報
    Summary Rex Energy Corp (Rex Energy) is an independent energy company. It carries out the acquisition, production, exploration and development of condensate, natural gas and natural gas liquids. It holds properties in Appalachian Basin. Rex Energy focuses on drilling and exploration activities in th …
  • HD Supply, Inc. (HDS):企業の財務・戦略的SWOT分析
    HD Supply, Inc. (HDS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Bayernoil Raffineriegesellschaft mbH:石油・ガス:M&Aディール及び事業提携情報
    Summary Bayernoil Raffineriegesellschaft mbH (Bayernoil) is an oil and gas company that offers refinery services to the oil and gas industry. The company provides products such as crude oil products, diesel, gasoline, fuel oil, bitumen, and others. It also offers liquefied fuels, heating oil, and sy …
  • Sirius XM Holdings Inc.:戦略・SWOT・企業財務分析
    Sirius XM Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Sirius XM Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • The Hokuetsu Bank, Ltd.:企業の戦略・SWOT・財務情報
    The Hokuetsu Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Hokuetsu Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Ahimsa Industries Limited:戦略・SWOT・企業財務分析
    Ahimsa Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Ahimsa Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • ARYZTA AG:企業のM&A・事業提携・投資動向
    ARYZTA AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ARYZTA AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • MicroPort Scientific Corp (853):企業の製品パイプライン分析2018
    Summary MicroPort Scientific Corp (MicroPort) a subsidiary of Otsuka Medical Devices Co Ltd is a medical device company which develops, manufactures and markets cardiovascular treatment devices. The company provides products such as cardiovascular devices, orthopedic devices, endovascular devices, e …
  • Checkpoint Surgical LLC:医療機器:M&Aディール及び事業提携情報
    Summary Checkpoint Surgical LLC (Checkpoint Surgical) is a medical device company that offers neuro-protective surgery equipment. The company offers neuro-protective devices including checkpoint stimulators and locators; and checkpoint head and neck systems. Its checkpoint stimulators and locators p …
  • McKinsey & Co Inc:企業の戦略的SWOT分析
    McKinsey & Co Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Regency Centers Corporation:企業のM&A・事業提携・投資動向
    Regency Centers Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Regency Centers Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Berkley Renewables Inc (BKS)-石油・ガス分野:企業M&A・提携分析
    Summary Berkley Renewables Inc (Berkley) is a venture firm that focuses on capturing opportunities in renewable energy, life sciences, and oil & gas sectors. The company essentially carries out power generation through the management and operation of solar photovoltaic plants . It also undertakes th …
  • Catalyst Paper Corp:企業の戦略的SWOT分析
    Catalyst Paper Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Sika Interplant Systems Limited
    Sika Interplant Systems Limited - Strategy, SWOT and Corporate Finance Report Summary Sika Interplant Systems Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Qiagen Marseille SA-製薬・医療分野:企業M&A・提携分析
    Summary Qiagen Marseille SA (HalioDx), formerly Ipsogen SA is a subsidiary of Qiagen NV, a drugs manufacturing company that develops and markets molecular diagnostic tests. The company offers products for the treatment of chronic myeloid, chronic lymphocytic, acute myeloid, and acute lymphoblastic l …
  • Isetan Mitsukoshi Holdings Ltd.:戦略・SWOT・企業財務分析
    Isetan Mitsukoshi Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary Isetan Mitsukoshi Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆